North America Structured Investments

24 month EFA capped BREN

The following is a summary of the terms of the notes offered by the preliminary pricing supplement highlighted below. Summary of Terms Issuer: JPMorgan Chase & Co. Minimum Denomination: $1,000 Index: iShares MSCI EAFE ETF Upside Leverage Factor: 2.00 Maximum Total Return: 22.00%-26.00%* Buffer Amount: 10% Ending Index Level: The Index closing level on the Observation Date Initial Index Level The Index closing level on the Pricing Date Pricing Date: March 28, 2016 Observation Date: March 26, 2018 Maturity Date: March 29, 2018 CUSIP: 48128GQB9 Preliminary Pricing Supplement: http://sp.jpmorgan.com/document/cusip/48128GQB9/doctype/Product_Termsheet/document.pdf For information about the estimated value of the notes, which likely will be lower than the price you paid for the notes, see the hyperlink above. Certain Product Characteristics If the Ending Index Level is greater than the Initial Index Level, you will receive a cash payment that provides you with a return per $1,000 principal amount note equal to the Index Return multiplied by the Upside Leverage Factor, subject to the Maximum Total Return on the notes. If the Ending Index Level is equal to or less than the Initial Index Level by up to the buffer amount, you will receive the principal amount of your notes at maturity. If the Index declines from its initial level by greater than the Buffer Amount, you will lose 1% of the principal amount of your notes for every 1% that the Index has declined beyond the Buffer Amount. Any payment on the notes is subject to the credit risk of JPMorgan Chase & Co.

* To be determined on the Pricing Date, but not less than 22.00% or greater than 26.00% ** Reflects a Maximum Total Return of 22.00% for illustrative purposes. The hypothetical returns and hypothetical payments on the Notes shown above apply only at maturity. These hypotheticals do not reflect fees or expenses that would be associated with any sale in the secondary market. If these fees and expenses were included, the hypothetical returns and hypothetical payments shown above would likely be lower

Hypothetical Returns on the Notes at Maturity** * To be determined on the Pricing Date, but not less than 22.00% or greater than 26.00% ** Reflects a Maximum Total Return of 22.00% for illustrative purposes. The hypothetical returns and hypothetical payments on the Notes shown above apply only at maturity. These hypotheticals do not reflect fees or expenses that would be associated with any sale in the secondary market. If these fees and expenses were included, the hypothetical returns and hypothetical payments shown above would likely be lower J.P. Morgan Structured Investments | 1 800 576 3529 | jpm_structured_investments@jpmorgan.com 24 month EFA capped BREN North America Structured Investments Hypothetical Index Return Hypothetical Note Return Hypothetical Payment at Maturity 80.00% 22.00% $1,220.00 50.00% 22.00% $1,220.00 40.00% 22.00% $1,220.00 15.00% 22.00% $1,220.00 11.00% 22.00% $1,220.00 10.00% 20.00% $1,200.00 5.00% 10.00% $1,100.00 0.00% 0.00% $1,000.00 -10.00% 0.00% $1,000.00 -15.00% -5.00% $950.00 -30.00% -20.00% $800.00 -40.00% -30.00% $700.00 -100.00% -90.00% $100.00 $700$800$900$1,000$1,100$1,200$

North America Structured Investments

24 month EFA capped BREN

Selected Risks •Your investment in the notes may result in a loss. •Payment on the notes at maturity is subject to our credit risk. Therefore the value of the notes prior to maturity will be subject to changes in the market’s view of our creditworthiness. •Your maximum gain on the notes is limited to the Maximum Total Return. •If the Index declines from its initial level by more than 10%, you could lose up to $900 for each $1,000 note. •No interest payments, dividend payments or voting rights. •The tax consequences of the notes may be uncertain. You should consult your tax advisor regarding the U.S. federal income tax consequences of an investment in the notes.

Selected Risks (continued) •JPMS’s estimated value will be lower than the original issue price (price to public) of the notes. •You are exposed to the risks associated with non-U.S. companies. •No direct exposure to fluctuations in foreign exchange rates •JPMS’s estimated value is not determined by references to our credit spreads for our conventional fixed rate debt. •JPMS’s estimated value does not represent future values and may differ from others’ estimates. •The value of the notes, which may be reflected in customer account statements, may be higher than JPMS’s current estimated value for a limited time period. •Lack of liquidity: J.P. Morgan Securities LLC, acting as agent for the Issuer (and who we refer to as JPMS), intends to offer to purchase the notes in the secondary market but is not required to do so. The price, if any, at which JPMS will be willing to purchase notes from you in the secondary market, if at all, may result in a significant loss of your principal. •Potential conflicts: We and our affiliates play a variety of roles in connection with the issuance of notes, including acting as calculation agent and hedging our obligations under the notes, and making the assumptions used to determine the pricing of the notes and the estimated value of the notes when the terms of the notes are set. It is possible that such hedging or other trading activities of J.P. Morgan or its affiliates could result in substantial returns for J.P. Morgan and its affiliates while the value of the notes decline.

The risks identified above are not exhaustive. Please see “Risk Factors” in the applicable product supplement and “Selected Risk Considerations” in the applicable preliminary pricing supplement for additional information.

Additional Information SEC Legend: JPMorgan Chase & Co. has filed a registration statement (including a prospectus) with the SEC for any offerings to which these materials relate. Before you invest, you should read the prospectus in that registration statement and the other documents relating to this offering that JPMorgan Chase & Co. has filed with the SEC for more complete information about JPMorgan Chase & Co. and this offering. You may get these documents without cost by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, JPMorgan Chase & Co., any agent or any dealer participating in the this offering will arrange to send you the prospectus and each prospectus supplement as well as any product supplement and preliminary pricing supplement if you so request by calling toll-free 1-866-535-9248. IRS Circular 230 Disclosure: JPMorgan Chase & Co. and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax matters contained herein (including any attachments) is not intended or written to be used, and cannot be used, in connection with the promotion, marketing or recommendation by anyone unaffiliated with JPMorgan Chase & Co. of any of the matters address herein or for the purpose of avoiding U.S. tax-related penalties. Investment suitability must be determined individually for each investor, and the financial instruments described herein may not be suitable for all investors. This information is not intended to provide and should not be relied upon as providing accounting, legal, regulatory or tax advice. Investors should consult with their own advisors as to these matters. This material is not a product of J.P. Morgan Research Departments. Free Writing Prospectus Filed Pursuant to Rule 433, Registration Statement No. 333-199966 J.P. Morgan Structured Investments | 1 800 576 3529 | jpm_structured_investments@jpmorgan.com